ARCHA at Aston University secures £400,000 to recruit four PhD students for dementia research

WASH­ING­TON — FDA Com­mis­sion­er Rob Califf took the podi­um Wednes­day af­ter­noon at the Na­tion­al Press Club, of­fer­ing up more warn­ings about mis­in­for­ma­tion lead­ing to de­clin­ing

Adding a PD-1 inhibitor to standard of care improved disease-free survival (DFS) in stage III soft-tissue sarcoma of the extremity, a randomized trial showed. In